Although desmoid tumors do not metastasize, they can be associated with recurrence rates of up to 77% after surgical resection. 6,9 Desmoid tumor experts and treatment guidelines now recommend ...

An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical ...

Learn how accelerating drug discovery is reshaping the pathway from lab findings to effective therapies with real-world data.

As Novartis moves ahead plans to expand Pluvicto's use based on the PSMAddition trial, experts urge for greater use of ...

Semaglutide reduces cardiovascular events by 23% and direct heart disease death risk by 26% compared to dulaglutide in older ...

When doctors review brain scans, each detail of the picture—each pixel or voxel—must be painstakingly labeled. The cerebral ...

The White House has raised concerns around women’s health, but R&D on pregnant and breastfeeding women is still lacking.

For years, MASH was where drug development dreams went to die.  | After Rezdiffra’s approval and Wegovy’s label expansion, ...

A PwC analysis shows that GLP-1 medications like Ozempic and Zepbound may be catalyzing a behavioral and economic shift that’s on par with major technological breakthroughs. A transformation that ...

Praxis Precision surges on positive ulixacaltamide data for essential tremor, but tolerability limits impact. Explore PRAX's ...

Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.

One day this summer, Pat McAfee, the former NFL punter turned ESPN personality, interviewed New York Jets cornerback Sauce ...